Opening conversation: how you experience CAPA today

• How would you briefly describe your current CAPA process and who on your team owns it day to day?
• In the last 12 months, how many CAPAs did your team open on average per month? Options: 0-5, 6-15, 16-30, 31-60, More than 60
• Which tools or spreadsheets currently capture CAPA details, investigations, and action tracking? Options: Spreadsheets, General QMS tool, Homegrown database, Shared documents, Paper records, Other
• Tell me about the most recent regulatory observation or audit comment related to CAPA, what it called out, and how your team responded.
• What does an average CAPA lifecycle look like in weeks, from event detection to effectiveness check? Options: Less than 4 weeks, 4-8 weeks, 2-3 months, 3-6 months, Longer than 6 months
• Is there an active remediation plan or regulatory deadline that forces you to change CAPA processes on a fixed timeline? Options: Yes, strict deadline, Yes, flexible timeline, No fixed deadline, Unsure

Where the process consistently trips you up

• If a recurring deviation keeps coming back, who on your leadership team would notice first and what typically happens next?
• What recurring CAPA patterns create the most downstream audit findings, repeat deviations, or production impact? Options: Root cause not identified, Actions incomplete, Effectiveness checks missing, Documentation gaps, Integration failures, Other
• How many CAPAs in the last year were closed and later reopened for the same issue? Options: 0, 1-2, 3-5, 6-10, More than 10
• When CAPAs fail to stick, which consequences hurt you most, for example release delays, audit citations, or customer complaints? Options: Release delays, Audit citations, Repeat customer complaints, Increased scrap/rework, Resource drain
• What single CAPA failure would make you stop a rollout or demand revisiting strategy immediately?

How investigations actually happen, not how they should

• Who leads most root cause investigations, and what prevents them from using rigorous methodologies every time? Options: Quality director, CAPA manager, Operations lead, Cross-functional team, External consultant
• Walk me through the last investigation that produced an effective corrective action, from trigger to verification.
• Which structured methods do you use today, such as 5-Why, fishbone, or fault tree, and when do you choose one over another? Options: 5-Why, Fishbone (Ishikawa), Fault tree analysis, FMEA, No consistent method, Other
• How long does a typical investigation take from assignment to published evidence, and where do delays accumulate? Options: Less than 1 week, 1-2 weeks, 2-4 weeks, More than 4 weeks
• If an inspector asked for proof that your investigation traced a systemic root cause, what evidence could you produce immediately? Options: Complete investigation report with root cause, Linked corrective actions with dates, Effectiveness check records, Partial evidence only, No immediate evidence

Who owns what when CAPA matters most

• Who approves CAPA closure, who signs electronic records, and where does accountability break down when actions fail? Options: Quality director, CAPA owner, Department head, Cross-functional approval, No clear approver
• Describe how cross-functional handoffs work between quality, manufacturing, and supply chain using a recent CAPA as an example.
• Which escalation paths exist when a CAPA action slips past its due date or impacts release? Options: Automated escalation to manager, Manual notification, Escalation to department head, Regulatory notification, No formal escalation
• On average, how many people are assigned to a high-risk CAPA and which roles are non-negotiable? Options: 1-2, 3-4, 5-7, More than 7
• If a required subject matter expert is unavailable for months, could you proceed with the CAPA or would that stop implementation? Options: Proceed with alternative SME, Pause until available, Escalate decision, Depends on risk level

Who else could you choose and why they look tempting

• What would have to be true for you to keep your current CAPA approach instead of moving to an external solution? Options: Meets regulatory expectations, Requires no new budget, Delivers equivalent evidence, Internal capacity exists, Other
• Which categories of options have you evaluated or are considering, for example incumbent QMS, point CAPA tools, or an internal build? Options: Incumbent enterprise QMS, Dedicated CAPA solution, Internal build/process change, Consulting program, Do nothing
• Have any teams proposed solving CAPA with internal process changes or headcount instead of new software, and who supported that idea? Options: Yes, executive-supported, Yes, operationally suggested, No internal proposal, Unsure
• How would you summarize the incumbent's main weakness that keeps you exploring alternatives?
• Which single internal obstacle could still block the purchase even after a successful pilot? Options: Budget constraints, Procurement cycle, Stakeholder resistance, Validation burden, Other

What would need to be ready before we start work

• Which integrations or data sources must be connected before configuration work begins, and who owns those connections? Options: ERP/Manufacturing data, Deviation system, Complaint system, LIMS, Batch records, Other
• Do your current systems provide APIs or flat exports for deviation, complaint, and batch data? Options: APIs available, Flat file exports available, Only manual exports, No access available, Unsure
• Who will be the technical point of contact for integration and do they have bandwidth allocated? Options: IT lead assigned, Integration engineer assigned, Quality systems analyst assigned, Third-party vendor, Not assigned yet
• How clean and accessible is the historical CAPA data needed for migration, and approximately how many records would you expect to bring over? Options: Clean and structured, ready, Partially clean, needs work, Unstructured, significant cleanup, Not available, Unsure
• Are there any regulatory reviews, legal approvals, or supplier agreements that will block going live on your target timeline? Options: Yes, will block, Yes, may delay, No known blockers, Unsure

How we'll measure success and when you'll sign off

• If your leadership asked for a single KPI that proves CAPA improvement, which metric would make them comfortable proceeding? Options: Reduction in repeat deviations, Time to close CAPA, Percent effectiveness checks passed, Reduction in CAPA-related audit findings, Other
• What target reduction in repeat deviations or audit observations would you require in a 6 to 12 month pilot to call it a success? Options: 10-20%, 21-40%, 41-60%, More than 60%, Other
• Which acceptance artifacts are mandatory for you, for example validation scripts, traceability matrix, and signed user requirements? Options: Validation scripts, Traceability matrix, Signed URS, Training records, Test evidence, Other
• Who will sign formal acceptance and who owns validation evidence after go-live? Options: Quality director signs, Head of manufacturing signs, Regulatory/compliance signs, Cross-functional signoff, Not decided
• If the pilot meets the numeric targets but validation takes longer than planned, would you approve a phased go-live or require full validation first? Options: Approve phased go-live, Require full validation before go-live, Case-by-case decision, Unsure

What happens next and who will move this forward

• What internal objections do you expect when you present a vendor-led CAPA solution and who will raise them? Options: Budget concerns, Validation burden, Integration risk, Change resistance, Procurement timing
• Which stakeholders must be involved in a two-week pilot and who has final say on greenlighting the program? Options: Quality director, CAPA manager, IT/integration lead, Manufacturing lead, Regulatory lead, Procurement
• By when are you targeting a decision and are there fixed procurement cycles we must align with? Options: Immediately, Within 30 days, 30-90 days, 3-6 months, Unsure
• Would you be willing to designate a single owner from your team as the project sponsor to speed approvals? Options: Yes, Maybe, No
• If we can run a short pilot that demonstrates your top KPI improving, what would stop you from signing a purchase order within two weeks? Options: Procurement constraints, Remaining validation concerns, Budget hold, Stakeholder disagreement, Nothing would stop us

• Investigation & Workflow Experience

• Confirm the current state and its cost
• You confirm the demonstrated workflow prevents superficial root cause analyses and links actions to auditable evidence.
• Provide three recent CAPA, deviation, or complaint records, redacted for confidentiality, to use as sample cases in the session.
• You acknowledge that the evidence shown would reduce recurring deviations and lower inspection risk in your environment.
• Walk an end-to-end structured investigation using your sample case
• Provide any recent regulatory observations related to CAPA (483 excerpts or summaries) to align the proof to inspection concerns.
• You agree on the specific validation artifacts and next milestones required before a procurement decision.
• Show how actions, implementation records, and effectiveness checks become auditable evidence
• Execute the structured investigation on the provided records and deliver the executed workflow evidence package prior to the follow-up session.
• Validate this maps to your needs
• List the stakeholders and approval roles required for validation sign-off and acceptance criteria.
• Agree remaining evidence and next milestones

• Investigation & Workflow Experience
• Solution Experience Deck
• Solution Brief: Investigation & Workflow Experience

• meeting
• slides
• document

• Configure event capture forms and workflows
• Enable investigation methodology toolset
• Configure corrective and preventive action planning
• Implement action assignment and progress tracking
• Configure automated escalations and notifications
• Integrate deviations, complaints, and audit findings
• Enable risk-based prioritization and scoring
• Configure management review dashboards and reports
• Configure electronic signatures and audit trail
• Implement effectiveness verification workflows
• Migrate existing CAPA records and history
• Provision user roles and access permissions
• Deliver validation documentation (IQ/OQ/PQ)

Configure event capture forms and workflows

• Do you currently capture CAPA initiation events in a structured form or free-text log (e.g., deviation report, complaint intake, audit finding)? Options: Structured forms, Free-text log, Both, No formal capture
• Which event types should pre-populate the CAPA intake form (e.g., deviation ID, customer complaint number, 483 observation reference)? Options: Deviations, Complaints, Audit findings, Regulatory observations, Lab OOS/OOT
• How many required data fields must appear on every event form (examples: device/batch number, product code, deviation ID, initial risk score)? Options: 3-5, 6-9, 10+
• What attachments must the form accept for investigational evidence (e.g., lab report PDFs, batch records, manufacturing lot traceability)? Options: PDFs (lab reports), Scanned batch records, Images/Photos, CSV test data, Other
• Who within your quality organization will perform initial triage of incoming events (roles such as CAPA coordinator, QA manager, QA reviewer)?
• When an event meets threshold for CAPA initiation, what initial status or workflow state should be set (e.g., 'Triage', 'Investigation opened', 'Under review')? Options: Triage, Investigation opened, Under review, Escalate to QA lead

Enable investigation methodology toolset

• Which structured investigation methods do you require built into the workflow (5-Why, fishbone/Ishikawa, fault tree analysis, laboratory failure mode analyses)? Options: 5-Why, Fishbone (Ishikawa), Fault Tree Analysis, FMEA-style, Other
• How should investigation templates capture evidence chains for regulatory inspection (for example: link deviation ID to raw data file, lab notebook page, and witness statement)?
• What roles must contribute to root cause steps for device or batch-level issues (e.g., production supervisor, QC analyst, process engineer)?
• Which artifact must be produced by every investigation step (examples: traceable root cause statement, corrective action rationale, hypothesis testing plan)? Options: Root cause statement, Hypothesis and test plan, Supporting evidence links, All of the above
• Provide the maximum allowed elapsed time for completing a formal investigation prior to escalation (e.g., 30 days for high-risk device events). Options: 7 days, 14 days, 30 days, Custom
• Who will own final sign-off of investigation findings that feed into device history or regulatory response letters?

Configure corrective and preventive action planning

• What corrective action planning fields are required for each CAPA (examples: action description, intended effect, target completion date, related deviation IDs)?
• Which preventive action triggers should auto-create CAPA tasks (for example: repeat deviation frequency threshold, trending out-of-specs in QC)? Options: Repeat deviations, Trend deviations, Supplier nonconformance, Audit trend
• How granular must action items be (task per work instruction update, task per supplier corrective action, task per equipment calibration)? Options: Per work instruction, Per supplier, Per equipment, Per batch
• Who approves corrective action plans before implementation into production (roles such as QA manager, head of manufacturing, regulatory affairs)?
• Which evidence will you attach to show an action was implemented (examples: revised SOP PDF, change control ID, training completion record)? Options: Revised SOP, Change control ID, Training completion record, Photographic evidence
• Are there actions that must trigger a change control or engineering change notice in your regulated system? Options: Yes, No, Depends on action type

Implement action assignment and progress tracking

• Who will be eligible assignees for CAPA action items (examples: individual users, role groups, functional teams such as QC, Manufacturing, Supplier QA)? Options: Individual users, Role groups, Functional teams
• How should action progress be measured and recorded (examples: percent complete, milestone dates, evidence attachments)? Options: Percent complete, Milestone dates, Evidence attachments, Combination
• What recurrence or reminder cadence do you want for overdue actions (for example: reminder at 3 days overdue, escalate at 7 days)? Options: Daily reminders, 3-day reminder then escalate, Weekly reminders, Custom cadence
• Which identifier must actions link to for traceability (deviation ID, complaint ID, batch/lot number)? Options: Deviation ID, Complaint ID, Batch/lot number, All applicable
• How will you demonstrate closure of an action item (evidence types such as signed work order, updated SOP version, training record)? Options: Signed work order, Updated SOP version, Training record, Photographic evidence
• Who will have permission to reassign or re-open completed actions during regulatory query responses?

Configure automated escalations and notifications

• Which events should trigger automated notifications (examples: new CAPA opened, action overdue, investigation signed)? Options: New CAPA opened, Action overdue, Investigation signed, Effectiveness check due
• What escalation path should be used for high-risk CAPAs (e.g., QA lead after 48 hours, VP Quality after 7 days)?
• How should notifications be delivered for inspection response readiness (email, platform inbox, integration to incident management)? Options: Email, Platform inbox, Incident management integration, Multiple
• Are there specific regulatory timelines to enforce by notification (for example: 15-day initial response to an FDA 483 item)? Options: Yes, No
• Who should receive audit-trail alerts for electronic signature events on CAPA records?
• Do you require notifications to include linked artifacts (e.g., attach deviation PDF, link to batch record)? Options: Yes, No

Integrate deviations, complaints, and audit findings

• Which source systems hold your deviation, complaint, and audit finding records that must integrate with CAPA (examples: LIMS, ERP, legacy QMS export)? Options: LIMS, ERP, Legacy QMS, Manual spreadsheets, Other
• How many unique integration endpoints must be configured at go-live (count API endpoints, SFTP feeds, or manual import templates)? Options: 1, 2-3, 4-6, 7+
• What matching key will link deviations/complaints to CAPA records (examples: deviation ID, complaint number, batch number)? Options: Deviation ID, Complaint number, Batch number, Custom mapping
• Which data fields must sync bi-directionally with source systems (e.g., status, owner, closure date)? Options: Status, Owner, Closure date, All listed
• Do you require a reconciliation report that shows unmatched legacy deviations after integration? Options: Yes, No
• Who will be the technical contact for API authentication and endpoint testing for each source system?

Enable risk-based prioritization and scoring

• Which risk factors should populate the CAPA prioritization algorithm (examples: patient safety impact, regulatory visibility, repeat occurrence rate)? Options: Patient safety impact, Regulatory visibility, Repeat occurrence, Production impact
• How should severity, probability, and detectability map to an overall priority score for device or batch events? Options: Predefined formula, Custom weighted formula, Manual override allowed
• What priority buckets are meaningful for your operations (examples: Critical, High, Medium, Low)? Options: Critical, High, Medium, Low
• Are there auto-escalation rules linked to priority (for example: Critical triggers immediate VP Quality notification)? Options: Yes, No
• Who can override the auto-calculated priority and what evidence must they record when doing so (for example: investigation rationale)?
• Do you require historical priority trend reports for management review and CAPA effectiveness audits? Options: Yes, No

Configure management review dashboards and reports

• Which KPIs must appear on the executive CAPA dashboard (examples: open CAPAs by priority, average time-to-close, recurrences per product line)? Options: Open CAPAs by priority, Average time-to-close, Recurrences per product line, Effectiveness pass rate
• What date ranges and filters do you need for management review exports (examples: fiscal quarter, product family, site)? Options: Fiscal quarter, Product family, Site, Custom date range
• How frequently should scheduled reports be emailed to reviewers (examples: weekly, monthly, quarterly)? Options: Weekly, Monthly, Quarterly, Ad hoc
• Who should have access to drill into raw CAPA evidence from a dashboard widget during review (roles such as QA reviewer, plant manager)?
• Do you require export formats certified for regulatory submission (examples: PDF with audit trail, CSV for analytics)? Options: PDF with audit trail, CSV, Both, Other
• Are management review templates standardized by any quality standard you follow (for example: ISO 13485 or internal SOP reference)? Options: ISO 13485, Internal SOP, Both, None

Configure electronic signatures and audit trail

• Which actions require an electronic signature under 21 CFR Part 11 for your organization (examples: investigation approval, CAPA closure, final effectiveness sign-off)? Options: Investigation approval, CAPA closure, Effectiveness sign-off, All listed
• How should signature events be captured for audit (elements such as user ID, timestamp, reason for signing, and linked artifact)?
• Do you require multi-factor authentication for e-signatures or privileged role access during CAPA review? Options: Yes, No
• Which retention period applies to signed CAPA records and audit trails per your SOPs or regulatory requirements? Options: 5 years, 10 years, As per SOP, Custom
• Who will be responsible for periodic audit of the electronic audit log for anomalies or unexplained signature events?
• Are there legacy printed signatures that must be linked to migrated CAPA records for inspection continuity? Options: Yes, No

Implement effectiveness verification workflows

• Which effectiveness check types must be supported (examples: trending over X months, targeted re-inspection, laboratory retesting)? Options: Trend analysis, Targeted re-inspection, Laboratory retesting, Supplier follow-up
• How long after action completion should an effectiveness check run for device or batch issues (examples: 3 months, 6 months)? Options: 1 month, 3 months, 6 months, Custom
• What data sources should the effectiveness workflow evaluate (examples: deviation trend, complaint frequency, production yield)? Options: Deviation trend, Complaint frequency, Production yield, QC test failures
• Who documents and signs the effectiveness verification result that will be available during inspection (roles such as QA effectiveness reviewer)?
• What evidence will validate that an effectiveness check is successful (examples: zero recurrence in trend window, statistical reduction in defect rate)? Options: Zero recurrence in trend window, Statistical defect reduction, Completed re-inspection report, Other
• Are effectiveness checks required to create a closed-loop entry that links back to the original deviation or complaint ID? Options: Yes, No

• Master Services Agreement (MSA)
• Statement of Work (SOW)
• Order Form / Subscription Agreement
• Validation & Acceptance Protocol
• Training Services Addendum
• Service Level Agreement (SLA)
• Data Processing Agreement (DPA)
• Change Order Agreement

• Go-live Health Check (weeks 1-4)
• First Measurement Review (weeks 4-10)
• Acceptance Gate Review (around day 90)
• Quarterly Effectiveness Review (ongoing)

• Publish the prioritized enhancement backlog items and schedule follow-up implementation or configuration windows.
• Restate acceptance criteria and numeric targets
• Produce a documented acceptance decision for each Solution Scope criterion, with named signatory for accepted items and a remediation plan for any failures.
• Confirm a single owner and timeline for incumbent system decommissioning or retention-read-only and for final data archive completion.
• Agree how acceptance evidence will be stored in the shared audit repository for future inspections.
• Publish the acceptance decision record with signatory names and the remediation plan for any failed criteria.
• Execute the incumbent system wind-down steps or confirm read-only retention and archive completion with evidence.
• Place acceptance evidence and representative investigation samples into the shared audit evidence channel for inspector readiness.
• Trend review for key metrics
• Validate that the deployment continues to meet the Solution Scope targets for repeat deviation rate and effectiveness-check completion, or capture corrective actions where it does not.
• Keep the audit evidence repository up to date with representative investigation and effectiveness-check samples for inspection readiness.
• Maintain a prioritized backlog of enhancements and process adjustments with owners and target dates.
• Assign owners and due dates for any corrective actions required to address metric regressions or recurring issues.
• Update the shared audit evidence channel with the quarterly sample set and document their location for inspectors.
• Reconfirm acceptance criteria and owners
• Confirm the deployment is technically complete against the Solution Scope configuration checklist and owners are assigned for any gaps.
• Identify and assign remediation for all high-priority blockers that prevent investigations or action tracking from proceeding.
• Agree date for the First Measurement Review and data sources to produce KPI reports.
• Document and distribute the remediation plan for open blockers with owner and target completion date.
• Confirm data sources and queries that will produce the KPI reports for the First Measurement Review.
• Ensure training completion for any user cohorts blocking investigative work and schedule follow-up sessions if needed.
• Present first-period metrics vs Solution Scope targets
• Determine whether early KPI trends are moving toward the Solution Scope targets and document the root causes for any shortfalls.
• Agree a concrete remediation plan with named owners and dates to correct metric shortfalls before the Acceptance Gate.
• Confirm the data extracts and report formats that will be used at the Acceptance Gate Review.
• Produce the KPI report extracts and sample investigation evidence required for the Acceptance Gate, delivered to stakeholders by the agreed date.
• Implement identified workflow or training changes and log completion in the deployment tracker.
• Remediate any integration or data quality issues that caused metric distortion before the Acceptance Gate.
• Deployment and migration verification
• Persistent issue and root-cause follow-up
• Root-cause diagnosis for any metric gaps
• Present outcome data and evidence per criterion
• Agree corrective remediation actions and owners
• Document pass/fail decision and capture named signatory
• Audit evidence readiness and spot sample review
• User onboarding and training status
• Confirm timeline and criteria for the Acceptance Gate
• Early adoption signals and usage patterns
• Remediation plan for failed criteria
• Enhancement requests and backlog management
• Incumbent system wind-down and data archiving checkpoint
• Open issues, blockers, and remediation plan